Drug Development

5th Biennial Biosimilars & Biobetters Congress

November 22, 2017

Over the past editions our 5th Biennial Biosimilars & Biobetters Congress has built up a reputation for delivering high-level content and bringing together the top senior executives and leaders within the Biosimilar industry. We would like to share with you some of the many highlights you should not miss from our 2018 conference programme: Day […]

19th Annual Drug Discovery Summit

November 20, 2017

Join over 300 leading experts for Europe’s most prestigious drug discovery congress at the 19th Annual Drug Discovery Summit, 7-8 June 2018, Berlin, Germany. Bringing you the latest research in drug discovery innovations and strategies, discovery enabling technologies and novel drug targets; our industry renowned speakers will give you the key insights you need to reduce costs […]

Drug Development: Making the impossible possible

November 20, 2017

THE Advancing Drug Development Forum has confirmed a prestigious line-up of leading industry voices to speak at its inaugural event. Taking place on November 30, 2017 in Boston, USA, the forum will see pharmaceutical experts and scientists from across the globe come together to exchange ideas and experiences and conduct a deep dive into the […]

WIRB-Copernicus Group Partners with Veeva Systems Inc.

November 20, 2017

WCG will create a seamless connection between WCG’s MyConnexus™ IRB document management web portal and Veeva Vault eTMF WIRB-Copernicus Group® (WCG™), the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced that it is partnering with Veeva Systems Inc. to improve the speed and accuracy of institutional review […]

FDA Renews and Expands its Portfolio of Simcyp Simulator (PBPK) Licenses

November 14, 2017

Increased Use of Physiologically-based Pharmacokinetic (PBPK) Modeling and Simulation (M&S) is a Priority in Both the Prescription Drug User Fee Act and Generic Drug User Fee Amendments Certara®, the global leader in model-informed drug development and regulatory science, today announced that the US Food and Drug Administration (FDA) has greatly expanded its use of Certara’s […]

iX Biopharma Starts Off 1Q18 on Sound Note

November 8, 2017

Singapore, 8 November 2017 – Specialty pharmaceutical company iX Biopharma Ltd (“iX Biopharma” or “the Group”) has reported results for its first financial quarter ended 30 September 2017 (“1Q18”) that reflects progress made in the development of its pharmaceutical products and preparations for the upcoming launch of its new range of next-generation nutraceutical products. Year-on-year, […]

BioIVT to Present Advances in Immunohistochemistry at AAPS Annual Meeting

November 8, 2017

BioIVT will also showcase its expanded research services resulting from its Qualyst Transporter Solutions and Asterand Bioscience™ acquisitions earlier this year BioIVT, a leading provider of biospecimens and related services, today announced that it will be presenting and exhibiting at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting. This conference will be held from […]

The Pistoia Alliance AbVance Project Reaches a Key Milestone with First Release of Antibody Structures into the Protein Data Bank

November 8, 2017

The AbVance project aims to accelerate biologics drug discovery by increasing knowledge of antibody structures in the public domain  The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D has announced today that its project to increase  knowledge of antibody (Ab) structures has reached its […]

FEEDBACK